HHS reform, vaccines, ACIP, CDC reform, NIH reform, Medicaid, Hospital at Home, NIH indirect for NIH and research, pediatric research, 340B, CHGME, Medicare conditions of participation rules, Whole genome payment, High-cost drugs, CMMI, OMB guidance, CMS SDP rule, NIH RFI's, OMB Guidance, NIH budget, behavior health
2026 · 3rd Quarter (July 1 - Sep 30)
CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER
Filed by CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER.
Open official filingSource-reported fields
Filing overview
- Type
- 3rd Quarter - Report
- Posted
- Oct 5, 2026
- Income
- Not reported
- Expenses
- $28,650.00
- Filing UUID
- d4268f91-2565-4082-ae3e-0f489898d4b8
- Termination date
- Not reported
Expense method: B
Literal source text
Lobbying issues and bill citations
vaccines, ACIP, 340B, cdc reform, nih reform, pediatric research, NIH budget, FAIR Act, indirect costs, whole genome sequencing, high cost drugs, CMMI, OMB guidance, K awards
340b, white bagging, FDA drug approval
Hospital at Home, Medicaid cuts, OBBBA, FY26 budget, HRSA, AHRQ, High cost drugs, CMS SDP rule, OMB guidance, AHRQ funding,
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.